Gilead Sciences Inc
GILD
$105.93-1.27 (-1.18%)
Jun 25, 2025, 4:00 PM
Financials
| 52Week High | 119.96 | 52Week Low | 66.01 |
| Beta | 0.35 | Current Ratio Annual | 1.60 |
| Current Ratio Quarterly | 1.37 | Gross Margin TTM | 78.29 |
| Market Cap | 131.59B | Net Profit Margin TTM | 20.76 |
| Operating Margin TTM | 28.61 | Price To Book | 6.87 |
| Price To Earnings TTM | 22.06 | Price To Free Cash Flow TTM | 13.69 |
| Price To Sales TTM | 4.58 | Quick Ratio Annual | 1.20 |
| Quick Ratio Quarterly | 1.00 | Return On Assets TTM | 10.67 |
| Return On Equity TTM | 31.74 | Return On Investment TTM | 15.89 |
| Revenue Growth3Y | 1.74 | Revenue Growth5Y | 5.08 |
| Revenue Growth Quarterly Yoy | -0.28 | Revenue Growth TTMYoy | 4.68 |
| Revenue Per Share TTM | 22.82 |
| Quarter | Funds | Added | Exited | Increased | Decreased | Unchanged | Shares | Value |
|---|---|---|---|---|---|---|---|---|
| Dec 31, 2024 | 1863 | 3 | 1 | 14 | 21 | 6 | 1.08B | $95.77B |
| Mar 31, 2025 | 1912 | 247 | 170 | 648 | 778 | 204 | 1.06B | $112.30B |
| Change | 49(3%) | 244(8133%) | 169(16900%) | 634(4529%) | 757(3605%) | 198(3300%) | 20.25M(2%) | $16.53B(17%) |